Rapid promotion and progression of fibrovascular polyps by inflammation and/or hyperplasia in hamster check pouch: implications for carcinogenesis assay.
Tumor initiation by topical application of 7,12-dimethylbenz[a]anthracene (DMBA) in dimethyl sulfoxide (DMSO) followed by topical application of retinyl acetate (RA), ethylphenylpropiolate, or acetic acid in DMSO at inflammatory and hyperplasiogenic dose regimens caused the rapid promotion of fibrovascular polyps with dysplastic epithelium in hamster cheek pouch. Such lesions did not occur in control animals initiated with DMBA followed by application of DMSO only, where inflammation was also minimal. At the dose regimen employed, RA caused obvious cytotoxicity and tissue destruction. With EPP and AA, there was no histological evidence of tissue destruction. At dose regimens resulting in minimal inflammation and no apparent cytotoxicity, RA promoted almost no polyps, but a higher yield of other tumor types. Thus, inflammation and/or hyperplasia apparently exerted a strong polyp-promoting and progressive influence. This and other differences between the tumorigenic responses of hamster-pouch mucosa and mouse skin suggest that the former supplement the latter in carcinogenic risk assessment.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000633:toxicity; D000085:Acetates / Q000633:toxicity; D000480:Alkynes / Q000633:toxicity; D000818:Animals; D002273:Carcinogens; D002610:Cheek / Q000187:drug effects; D006224:Cricetinae; D004224:Diterpenes; D006965:Hyperplasia / Q000139:chemically induced / Q000473:pathology*; D051379:Mice; D009374:Neoplasms, Experimental / Q000473:pathology; D011127:Polyps / Q000139:chemically induced / Q000473:pathology*; D000084562:Retinyl Esters; D014801:Vitamin A / Q000031:analogs & derivatives / Q000633:toxicity
D000085:Acetates; D000480:Alkynes; D002273:Carcinogens; D004224:Diterpenes; D000084562:Retinyl Esters; D014801:Vitamin A; C015202:ethylphenylpropiolate; C009166:retinol acetate; D015127:9,10-Dimethyl-1,2-benzanthracene